These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 8442095
1. Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation. Heath WR, Miller JF, Sprent J. Transplant Proc; 1993 Feb; 25(1 Pt 2):1222-4. PubMed ID: 8442095 [No Abstract] [Full Text] [Related]
3. Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism. Miconnet I, Bruley-Rosset M, Halle-Pannenko O. Transplant Proc; 1993 Feb; 25(1 Pt 1):327-8. PubMed ID: 8438320 [No Abstract] [Full Text] [Related]
8. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE. J Immunol; 1996 Dec 01; 157(11):4811-21. PubMed ID: 8943383 [Abstract] [Full Text] [Related]
9. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Li JM, Waller EK. Biol Blood Marrow Transplant; 2004 Aug 01; 10(8):540-51. PubMed ID: 15282532 [Abstract] [Full Text] [Related]
10. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells. Tang W, Yang Y, Zhang F, Li YC, Zhou R, Wang JX, Zhu YN, Li XY, Yang YF, Zuo JP. Int Immunopharmacol; 2005 Dec 01; 5(13-14):1904-13. PubMed ID: 16275625 [Abstract] [Full Text] [Related]
11. Low-dose heparin inhibits acute graft versus host disease in mice. Naparstek E, Slavin S, Weiss L, Sidi H, Ohana M, Reich S, Vlodavsky I, Cohen IR, Naparstek Y. Bone Marrow Transplant; 1993 Sep 01; 12(3):185-9. PubMed ID: 8241974 [Abstract] [Full Text] [Related]
17. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia. Champlin R, Jansen J, Ho W, Gajewski J, Nimer S, Lee K, Territo M, Winston D, Tricot G, Reichert T. Transplant Proc; 1991 Feb 01; 23(1 Pt 2):1695-6. PubMed ID: 1899162 [No Abstract] [Full Text] [Related]
18. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Li JM, Gorechlad J, Larsen CP, Waller EK. Biol Blood Marrow Transplant; 2006 Dec 01; 12(12):1239-49. PubMed ID: 17162205 [Abstract] [Full Text] [Related]
20. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease. Aizawa S, Kamisaku H, Sado T. Bone Marrow Transplant; 1995 Oct 01; 16(4):603-9. PubMed ID: 8528179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]